Adjuvant approaches to renal cell carcinoma

Clinical Advances in Hematology and Oncology

Volumn 6, Issue 1, 2008, Pages 19-21

  Wood, Christopher G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CANCER VACCINE; HEAT SHOCK PROTEIN 96 VACCINE; KI 67 ANTIGEN; LENALIDOMIDE; MONOCLONAL ANTIBODY G250; ONCOPHAGE; PLACEBO; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; THALIDOMIDE; UNCLASSIFIED DRUG; VITESPIN VACCINE;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG SYNTHESIS; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; PATIENT SELECTION; PROGNOSIS; RISK ASSESSMENT; KIDNEY TUMOR; METHODOLOGY; REVIEW; TUMOR RECURRENCE;

CARCINOMA, RENAL CELL; CLINICAL TRIALS AS TOPIC; HUMANS; KIDNEY NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL;

EID: 41449093920     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Jacobsohn KM, Wood CG. Adjuvant therapy for renal cell carcinoma, Semin Oncol. 2006;33:576-582.
2. Jonasch E. Presurgical therapy in metastatic renal cell carcinoma. Expert Rev Anti-cancer Ther. 2007;7:73-78.
3. Kunkle DA, Haas NB. Uzzo RG. Adjuvant therapy for high-risk renal cell carcinoma patients. Curr Urol Rep. 2007;8:19-30.
4. Kwak C, Park YH, Jeong CW, Lee SE, Ku JH. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma? Urol Oncol 2007;25:310-316.
5. Wood CG. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res. 2007;13(12 pt 2):697s-702s.
6. Yap TA, Eisen TG. Adjuvant therapy of renal cell Carcinoma. Clin Genitourin Cancer. 2006;5:120-130.